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rain) and peak doses of dobutsmine. Rest and stress left ventric- 
scores were derived from analysis of regianal 
4uw subjects underwent amnary angiugraphy. 
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Various noninvasivc tests have been evaluated for their ability to 
dctcct coronary artcry disease in patients with dilated cardiomy- 
opathy (I-14). The dctcction of coronary artery disca.. in this 
group of patients is important li,r both thcrapcutie and prognostic 
reasons (1.5-21). Eehoeardiography performed at r& is widely 
used to evaluate patients with dilated ~rdi~m~thy. Unfortu- 
nately, the frcqucncy of regional wall motion abnormalities at rest 
in nonixkmic wdiomyopthy and the prcscnec of global dys- 
Function in cnts with advanced ischemic cardiomyopathy 
prcvcnt accu identification of coronary artery disease (1,2). 
Exercise stress testing is the standard r.onhrvasive technique 
used for the dctcction of coronary artery disease in patients 
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athy. This technique has big 
arter)r disease but only mode 
without dilated ~rdi~)lily~~~t~y. Esercisc testing k not rou- 
tinely used for diagnostic purposes in patients with dilated 
cardiomyopathy because of their reduced ability to perform 
dynamic stress. Additionally, the frequency of elcctrocardio- 
graphic (ECG) abnormalities at rest impairs intcrprctation of 
the stress ECG. 
Dobutamine stress echocardiography is an cmcrging tech- 
nique that has been found to accurately identify patients with 
coronary artery disease ( 22-24). A major advantage of this 
stress-testing technique is that its accuracy is not dependent on 
the patient’s ability to exercise, Additionally, high quality 
images can be obtained that permit improved analysis of 
regional and global systolic function at various degrees of 
stress. The normal response of the left ventricle to increasing 
doses of dobutamine in the absence of coronary artery disease 
is a progressive increase in contractility. In the presence of 
significant coronary artery disease, contractility may initially 
improve at low doses of dobutaminc, but regional and global 
function may decline at higher doses that produce myocardial 
stress and ischemia (22). 
In this study, patients who had dilated cardiomyopathy 
underwent dobutamine stress echocardiography to determine 
whether stress-induced changes in wall motion could distin- 
guish patients with coronary artery disease from those without. 
We selected patients with left ventricular dilation and exten- 
07x5-1097/94/.S7.00 
etween 1988andJan 
tamine stress echoc 
ventricular dinstoli 
~~bu~~~rnalisies with 
0.25 to OX-mg doses in patients with inadequate heart rate 
responses to dobutamine infusion, as determined by the phy 
sician monitoring the test. 
~obu~mine infusion was term 
tocol dose or a target heart rate 
predicted maximum was achieved. 
angina or significant ST segment depression developed. Induction 
of wall motion abuorrn~ities was not used routinely as an end 
point in dobutamine echocardiogcaphic studies performed after 
October 1989. However, in this group of patients with dilated 
cardiomyopathy, development of additional wall motion abnor- 
malities in two or more segments remained a reason for test 
onal end points include 
ias or side effects. 
ischemia occurred, subli 
or intravenous esmolol (0.25 m@kg) was a 
discretion of the investigator. 
Stress ~lec~~~a~iog~p~y. Continuous ECG monitoring 
was performed, A IZlead system was used PW 51 patients, and 
three bipolar leads were monitored in the remaining 19 
patients. The stress ECG was interpreted as normal, ischemic 
or nondiagnostic. Ischemic hange ; were ned as the devel- 
opment of ST segment depression 21 in a lead with a 
normal baseline or 22 mm ST segment depression occurring in 
the presence of ST segment abnormalities atrest. Stress ECG 
findings were considered nondiagnostic in the presence of left 
bundle branch block or digitalis therapy or if ST segment 
depression <2 mm occurred in the setting of baseline ST 
segment abnormalities. 
Electrocardiographic monitoring was continued for 26 min 
after discontinuation of the infusion. 
The four standard echocardio- 
images for each view. 
The images were interpreted by an investigator who had no 
knowledge of the clinical history, stress ECG results and 
raphic data. Iln the absence of coronary artery disease, 
expected normal response to increasing doses of dobut- 
ne is a progressive increase in wall motion and thickening. 
i~~~rove wall motion from the low to 
infusion was defined as an 
resence of ~jgn~fica~~t 
e left ventricle was divided into 16 segments o evaluate 
reg~~flal Wall motion. A global wall motion score index was 
rch stage by summation of all se 
number of scored segments for ea 
examination (25). Regional wall otiou score indexes were 
erived for the territories upplied by the left anterior descend- 
Ing coronary artery (anterior region) and for segments sup- 
plied by the left circumflex and right coronary arteries (poste- 
rior region) (26). Segmental wall motion was graded on a scale 
of 1 to 4. A score of 1 represented normal wall motion at rest 
and hyperkinesia with dobutaln~ne infusion. Segments with 
bypokinesia atrest received ascore of 2. Segments witl: normal 
wall motion at rest were considered to have stress-induced 
bypokinesia f there was a lack of improvement ora reduction 
in wall motion from rest to 101~ dose or low to peak dose. 
Akinetic segments were given a score of 3 and dyskinetic 
segments a score of 4. 
Patients demonstrating a progressive improvement inwall 
motion manifested by a decrease in wall motion score during 
dobutamine infusion were considered to have nonischemic 
cardiomyopathy. Patients who had no improvement or wors- 
ening of wall motion with dobutamine manifested by no 
change or an increase in wall motion score from the low to 
peak dose stages were considered to have ischemic ardio- 
myopathy. 
C~rQ~~ . Fifty-four patients (77%) under- 
went coronary angiography. Visual assessment of the angio- 
grams was initially performed to identify arteries with any 
degree of stenosis. Manual caliper measurements were then 
obtained from the tine film image that demonstrated the most 
severe stenosis by an investigator with no knowledge of the 
clinical, ECG and echocardiographic data. One angiogram was 
evaluated by visual estimation because of technical factors that 
prevented caliper measurement. 
Significant coronary artery disease was defined as z%% 
reduction in the absolute lumen diameter of a major epicardial 
artery or major branch vessel, Patients who had significant 
narrowing of at least one major coronary artery were consid- 
ered to have ischemic ardiomyopathy. 
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T&k 1. Medication Profile Table 2. Stress Test End Points 
lschemic 
(nFz, 
Nonischemic 
(“:?I) 
DCM, 
No Cath 
(n = 16) 
Calcium channel blockcn 13 (32%) 2 (14%) 8 (50%) 
Reta-blockers 6 (15%) 0 I (6%) 
Nitrates 29 (73%)” 4 (29%)’ 8 (50%) 
ACE inhibitors 19 (48%) 10 (71%) 6 (38%) 
Digonin 21(51%) 6 (43%) 3 (19%) 
No therapy 4 (10%) 2(14%) 2 (13%) 
Monotherapy 6 (15%) 3 (21%) 7 (44%) 
Twrwlrug rherdpj 10 (25%) 7 (50%) I (6%) 
Three or more drugs 20 (50%)? 2 (14%)? 6 (38%) 
*p = 0,005. tp = 0.027. ACE = an8iotensin.convcrtiny enzyme; Cath = 
lschemic Nonischemic DCM, 
DCM DCM No Cath 
(n = 40) (n = 14) (n = 16) 
THR or max doss 2x (70%) 10(71%) 11 (69%) 
Angina 3(7cr) 0 (0%) 0 (03) 
Wall motion abnormality 5 (13%) 1(7%) 3(1Y%) 
Dyspnea 2 (5%) 1(7%) 0 (0%) 
Ventricular arrhythmia 2 (5%) I (7%) 1(6%) 
Side effects 0 (0%) I (7s) 1(6%) 
max = m;lrimal; THR = target heart rate; other abbreviations as in Table 1. 
cwronary angiognphy; DCM 5 dilated cardiomyopathy. 
Statisticat analysis. Data are given as the mean vah~e 
mSD. Descriptive data are given for all three groups. Compar- 
isons were performed only in those patients who had coronary 
angiography. The Fisher exact test was used to compare 
categoric variables, and at test was used to analyze continuous 
variables, Global wall motion scores were compared in the two 
groups with repeated measures analysis of variance. The 
grouping factor was the presence or absence of coronary artery 
disease, and the repeated measure was the dobutamine dose 
(rest, low and peak). A significant interaction term indicates 
that the pattern of change with drug is different in the two 
diagnostic groups. When the interaction term was significant, 
I tests were used to analyze the changes in global wall motion 
scores between rest and low dose and between low and peak 
dose to assess more precisely whcrc these changes occurred. 
than three complexes were seen in two patients, and all excess 
ventricular cctopic activity resolved after discontinuation of 
the infusion. No patient with ventric~i~~r arrhythmia bad 
hypotension. Of the remaining studies, five wcrc discoutitl~cd 
because of dyspnea (n = 3) nausea (II = 1) and back pain (n = 
I). All side effects resolved promptly wit ternlit~i~tio~~ of the 
esults 
Clinical data. Patients had a mean age of 5X years (range 
24 to 78), and 30 patients had a history of congestive heart 
failure. ~cnty-hvo patients reported chest pain symptoms, 
and five complained of dyspnca on exertion. 
y. Fifty-four of the 70 
ography. Fourteen patients 
had normal findings or insignificant coronary artery disease. 
Forty patients had significant coronary artery disease. Singlc- 
vessel disease was present in 13 (32%) of 40 patients, two- 
vessel disease in IS (45%) and three-vessel disease in 9 (23%). 
Two of the patients with triple-vessel disease also had signifi- 
cant left main coronary artery disease. As shown in Table 3, the 
pretest prcvalencc of angina, history of myocardia! infarction 
and Q waves on the EXE were significa 
with isc~e~ic car~i~rny~~thy. Left bu branch block was 
more frequent in those with nonischemic cardiomyopathy, and 
the cy of heart failure was similar in both groups. 
namlc and ECG data. Table 4 demonstrates the 
Sixty-two patients (88%) were receiving medical therapy at 
the time of the study. As shown in Table 1, only the use of 
nitroglycerin-containing preparations and treatment with mul- 
tiple medications were more common in the group with 
comnary artery disease. 
hemodynamic and ECG responses to dobutamine stress testing. 
Rest and peak heart rates in the group with ischemic cardiomy- 
opathy were significantly lower than those in the group with 
nonischemic cardiomyopathy. This observation for peak heart 
rate remained despite correction for the difference in mean age. 
Test end paints and safety data. The results were evalu- 
ated to determine the safety of dabutamine administration in 
patients with dilated cardiomyopathy. As shown in Table 2,49 
(70%) of 70 studies were terminated after achievement of the 
target heart rate or the maximal protocol dose. An ischemic 
end point was achieved in 12 patients (17%). Three patients 
had severe angina, and in nine patients the test was terminated 
&UIS~ of extensive stress-induced wall motion abnormalities. 
No patient experienced prolonged ischemia. Ischemia was 
treated with sublingual nitroglycerin in two patients and intra- 
venous esmolol in two others. Resolution of ischemia occurred 
in the remaining eight patients without additional measures. 
Ventricular arrhythmias prompted test discontinuation in 4 
(6%) of 70 studies. Episodes of ventricular tachycardia longer 
The ECG response was nondiagnostic in the majority of 
patients in both the ischcmic and nonischemic groups because 
of a high frequency of baseline ECG abnormalities. No test 
was terminated because of ECG changes. Three (7%) of the 40 
patients with ischemic cardiomyopathy and 1 (7%) of the 14 
Table 3. Clinical and Electrocardiographic Characteristics 
lschcmic DCM Nonischcmic DCM p 
(n = 40) (n = 14) Value 
Mean (+SD) age (yr) 622 11 482 12 < 0.001 
Angina 20 (50%) 2(14%) 0.027 
Prior infarction 27 (68%) I (7%) < 0.001 
Heart failure 16 (40%) 9(64%) NS 
Exertional dyspnea 3 (7%) 1(7%) NS 
Q waves 20 (50%) 2(140/o) 0.0; : 
Left bundle branch block 4 (10%) 7 (50%) O&l4 
DCM = dilated cardiomyopathy. 
diastolic diametu was burger in patients with nonischemic (hh7 I 
1.20) th ishmic (6.00 rl: 0.64) ci~lrliosyopi~lIly (19 L 0.02). 
However, there were no signiticant di~ferc~lccs in the values for 
fractional shortening (0.14 -C 0.M vs. 0.13 I! 0.05) and fractional 
area change (0.24 + 0.10 vs. O.-l 7 4 0.12) in patients with and 
without coronary artery disease. All of the patients with nonisch- 
emit cardiomyopathy had regional wall motion abnormalities. 
Three of the 40 subjects with ischemic cardiomyopathy had global 
~~~I~oS~~C ~~~~i~y ~~~~~~~~~~~ Marion snores. The individ- 
ual and mean global wall motion scores for the two groups of 
patients ilK shown in Figure 1. Mean rest global wall motion 
score was significantly worse in the group with no&hemrc 
cardiomyopathy (2.34 f 0.42 vs. 2.08 + 0.35, p = 0.028). Therz 
were no significant differences in mean wall motion scores at low 
and peak dose bclwecn the two groups. In patients with ischcmic 
3- 
2.5 - 
2- 
*.!5- 
l- 
3 
1 
global wa 1 motion score demonstrated a 
sive ~mp~~)veme~t in wall motion score from rest to low (2.14 t 
0.38) to peak doses (1.91 2 0.43) of dob~tarn~~e. The interaction 
term from the repeated measures analysis of variance was highly 
Further analysis indicated that both 
in g!obal wall motion score from rest 
owever, the patients with coronary 
artery disease showed an increase in score from low to peak dose, 
whereas the patients without coronary artery disease had de- 
creased scores. This difference in response was significant (p < 
c1.001). 
Evaluation of changes in global wall motion score from low to 
citk dose correctly identified 33 of 40 patients with and 10 of 14 
ithout significant coronary artery disease. Overall sen- 
ohtnamine stress cchocardiography for detecting cos- 
disease was 83%; specificity was 71% The positive 
predictive value for dohutamine stress cchocar 
KY;;:: the negative predictive value was 59%. 
Of the patients with left main or three-vessel coronary 
artery disease, nine (100%) of nine were correctly detected. 
Fifteen (83%) of 18 patients with two-vessel coronary artery 
disease and Y (69%) of 13 patients with single-vessel disease 
were also correctly detected. If lesions >75% were considered, 
then all of the patients with two-vessel coronary artery disease 
were correctly identified as having significant disease. All six of 
the patients with ischemic cardiomyopathy who were receiving 
beta-adrenergic blocking agents were correctly identified even 
though none achieved his or her target heart rate. 
Four patients in the group with sizg!~‘-:‘::::r:! disease had 
false negative findings for ischcmic cardiomyopathy because of 
improvement in global wall motion score from low to peak 
dose. One patient had total occlusion of the right coronary 
Figure 1. Global wati morion scores 
for the 14 patients with nonischemic 
cxdiomyopathy (left) and the 40 
subjects with ischemic cardiomyopa- 
thy (right). Bold tines indicate mean 
values for each group. 
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artery but demonstrated extensive left to right collateral Ves- 
sels. A second patient with a diseased left circumflex artery had 
some worsening of wa!l motion in the posterior region but 
demonstrated improvement in global wall motion score be- 
cause of greater imrprovement in anterior wall motion. TWO 
other patients had improvement in global wall motion score 
despite left anterior descending coronary artery stenoses Of 
50% to 75%. 
Three patients with two-vessel coronary artery disease also 
demonstrated unexpected tmprovement in giobal wall motion 
score, All three had significau: disease of the left circumflex 
and right coronary arteries without involvement of the left 
anterior descending coronary artery. Two had severe baseline 
wall motion abnormalities involving the inferopostcrior seg- 
ments, In these patients. wall motion improved in anterior 
segments, resulting in an overall improvement in global Wall 
motion score. The third patient had a poor response to 
dobutaminc (peak heart rate 96 heatslmin). 
Four patients with nonischcmic ardiomyopathy had uncx- 
pectcd worsening of glol~al wall motion score from low to peak 
dose. Two of these patients had both severe left ventricular 
dilation (diastolic dimensions 6.8 and 9.X cm) and severely 
reduced systolic function (fractional shortening of 0.06 and 0.11 
and fractional area change 0.07 and 0.06). Additionally, these two 
patients and one other with a false positive study had left bundle 
branch block. A fourth patient with nonischemic ardiomyopathy 
and worsening of wall motion from low to peak dose had left 
ventricular hypertrophy and achieved a high ICVCI of stress (lXak 
heart rate 144 beatslmin). 
Diagnostic utility ofregional wall motion scores. The sunsi- 
tivity for detection of ischcmic ardiomyopathy improved to 93% 
(37 of 40) with analysis of regional wall motion suorcs. If patients 
with ischemic cardiomyopathy wcrc idcntilied on the basis of a 
lack of improvomcnt or worsening of wall motion score in at least 
one region (anterior or posterior), then four of seven subjects 
with false negative findings (on the basis of global wall motion 
scxxcs) would have been correctly diagnosed. 
However, assessment of changes in regional wall motion 
scores would have decreased the specificity for detection of 
ischcmic cardiomyopathy from 71% (10 of 14) to 50% (7 of 
14). Global wall motion scores improved from low to peak dose 
in 10 patients with nonischemic ardiomyopathy, but only 7 of 
these patients had improvement in both anterior and posterior 
regions. In the remaining three subjects, anterior wall motion 
scores demonstrated no improvement. 
in the 37 patients with ischemic cardiomyopathy who were 
correctly identified on the basis of regional wall motion scores, the 
low to peak dose changes in these scores correctly identified the 
location of significantly diseased vessels in 55 (74%) of 74 regions. 
Discussion 
Multiple noninvasive approaches have been used to identify 
coronary artery disease in patients with dilated cardiomyopathy 
(I-14). Echocardiographic and nuclear angiographic techniques 
use analysis of regional wall motion for detection of coronary 
artery disease. Regional wall motion abnormalities in patients 
with normal left ventricular dimensions can accurately identify 
patients with coromuy artery disease. Mcdina et al. (I) demon- 
strated a 95% sensitivity and RIO% specificity for the cchocardio- 
graphic identification of coronary artery disease in 43 patients 
with normal left ventricular size and reduced left ventricular 
systolic function. The presence of regional wall motion ahnormal- 
ities in patients with dilated cardiomyopathy, however, is not as 
sensitive or specific. Medina et al. (1) found that the presence of 
regional wall motion ahnormalities in 60 patients with left ven- 
tricular dilation had a sensitivity and specificity of only 83% and 
57%. respectively, for the presence of coronary artety disease. 
Others (4.14) have reported that up to two-thirds of ~~~ti~~ts wi h
nonischemic ardiomyopathy have regional wall motion abnor- 
malities at rest. In our study, ail of the patients with nonischemic 
cardiomyopathy had regional wall motion i~~~ll~~~mi~lities. 
In the absence of coronary artery disease, increasing doses 
of dobutamine produce hypcrkinctic wall motion. In the 
presence of coronary artery disease, the increased work load 
resulting from high dose dobtttaminc infusion products isch- 
emia with worsening of wall motion. This ditfcrencc in wall 
motion response enables accurate deiection of coronary artery 
disease in patients without dilated cardiomyopathy (22-24). In 
general, the low to peak dose changes in global wall motion 
score were useful for distinguishing patients with ischemic and 
nonischemic ardiomyopathy. Those patients with more exten- 
sive or severe coronary artery disease (left main coronary 
artcry, three-vessel or two-vessel disease with >7S% stenosis) 
were correctly detected with a sensitivity of 100%. However, 
the sensitivity declined in patients with less extensive disease. 
The unexpected improvement in global wall motion score 
observed in those patients with dilated cardiomyopathy and less 
extensive coronary artery disease may have several explanations. 
The left ventricular dysfunction in these patients may have both 
ischemic and nonischemic auses. In this investigation, there was 
a higher proportion of single-vessel disease in the ischemic 
cardiomyopathy group than has been reported in other studies 
(1,4,9-11). Regions with reduced function but no significant 
coronary artery disease may demonstrate improvement in wall 
motion with dnbutamine, whereas regions supplied by stenotic 
coronary arteries may worsen slightly or not at all if these areas 
have extensive or complete infarction, This situation occurred in 
three of seven false negative findings and resulted in an improve- 
ment in global wall motion score from low to peak doss despite 
the presence of significant coronary artery disease. 
This technique also relied on the demonstration of ischemia 
for detection of coronary artery disease. The presence of 
extensive collateral vessels or the lack of functional flow 
restriction despite angiographic narrowing could prevent isch- 
emia and result in unexpected improvement in wall motion. 
Additionally, failure to attain sufficient myocardial stress to 
produce ischemia may result in false negative findings. In 
dilated cardiomyopathy, dobutamine administration may re- 
duce preload and afterload, limiting the induction of ischemia. 
The specificity of dobutamine stress echocardiography in 
this study was lower than that reported in patients with normal 
JACC VCII “4 No 4 ._, . 
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could no longer rcspon 
without coronary artery disease. ~dd~ti~~ally, reduced coro- 
nary flow rescrvc has been observed in some patients with 
dilated cardi~~~lyo~at~y and my resdt in stress-induced myo- 
cmia even in the absence of epicardial coronary 
artery disease (27,28). 
Three patients with false positive findings had left bundle 
. Left bundle branch block results in asynchronous 
ction. which may alter scpt: perfusion and pro- 
a in the ihSCllCC Of epical ial COlottitty ttrtcty 
‘Fhc nomh atients with nonisch- 
bpitthy WilS Silli\ll, SO thi any conclusions with 
regard to the specificity of dohut: stress echocardiogra- 
phy must be ma& with caution. rcntiation of ischemic 
and nonischemic cardiomyopathy on the basis of coro- 
nary angiography is imprecise because more than one process 
may be present simultaneously, and angiography does not 
provide a physiologic assessment of the severity of coronary 
artery disease. Finally, analysis of wall motion was limited to 
utaminc stress cc ~cardi~~grap~iy is a 
widely available technique that can safely provide diagnostic 
information in patients with dilated cardiomyopathy. The wall 
motion changes induced with progressive doses :lf dobutamine 
identified patients with extensive coronary artery disease with 
a high sensitivity. However, only a modest specificity was 
achieved by evaluation of changes in pi&al wall motion score. 
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